ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Alloantibodies"

  • 2015 American Transplant Congress

    In Vitro Evidence That CTLA4Ig Attenuates Recall Alloantibody Responses

    I. Kim,1 G. Wu,1 N.-N. Chai,1 S. Jordan,2 A. Klein.1

    1Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA; 2Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background: CTLA4Ig is an agonist that blocks CD28-B7 costimulation, downregulating T cell immunity, but also appears to negate T cell-dependent B cell activation, thus inhibiting…
  • 2015 American Transplant Congress

    NK-Cell Subset Distribution, Renal Function and Biopsy Findings in Kidney Transplant Recipients With HLA Donor-Specific Antibodies

    M. Crespo,1 D. Redondo,1 J. Gimeno,2 J. Yelamos,3 A. Muntasell,3 A. Faura,1 M. Pérez-Sáez,1 M. López-Montañes,4 A. Torío,5 C. García,6 M. Mir,1 J. Hernandez,6 M. López-Botet,3,4 J. Pascual.1

    1Nephrology Unit, Hospital del Mar, Barcelona, Spain; 2Servicio de Anatomía Patológica, Hospital del Mar, Barcelona, Spain; 3Servicio de Inmunología, Institut Mar d'Investigacions Mediques, Barcelona, Spain; 4Universitat Pompeu Fabra, Barcelona, Spain; 5Laboratori de Referencia de Catalunya, Barcelona, Spain; 6Immunology Department, Hospital de Alicante, Alicante, Spain.

    Background: Detection of post-transplant donor-specific anti-HLA antibodies(DSA) constitutes a risk factor for kidney transplant (KT) loss. NK-cell antibody-dependent cell mediated cytotoxicity(ADCC) has been proposed to…
  • 2015 American Transplant Congress

    Endosome-Based Activation of Non-Canonical NF-kB Signaling By Membrane Attack Complexes

    D. Jane-wit,1 Y. Surovtseva,2 L. Qin,3 P. Clark,4 T. Manes,4 M. Kashgarian,5 N. Kirkiles-Smith,4 R. Liu,4 C. Wang,4 G. Tellides,3 J. Pober.4

    1Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT; 2Yale Center for Molecular Discovery, Yale University School of Medicine, New Haven, CT; 3Department of Surgery, Yale University School of Medicine, New Haven, CT; 4Department of Immunobiology, Yale University School of Medicine, New Haven, CT; 5Department of Pathology, Yale University School of Medicine, New Haven, CT.

    Using sera from transplant patients with high-titer panel reactive antibody (PRA), we previously described a model for studying the effects of alloantibody binding and complement…
  • 2015 American Transplant Congress

    CN Inhibition (But Not mTOR Inhibition) of a Novel CD8+ T Cell Regulatory Mechanism Results in Higher Alloantibody Posttransplant

    J. Zimmerer, S. Elzein, C. Wright, G. Bumgardner.

    Department of Surgery, CTC, The Ohio State University Wexner Medical Center, Columbus, OH.

    MTOR inhibitors [mTORi; Rapamycin, (Rapa)] and calcineurin inhibitors [CNi; Tacrolimus (Tac)] are immunosuppressive drugs commonly used to suppress the rejection of transplanted organs and tissues.…
  • 2015 American Transplant Congress

    Immunological Characterization of Full Facial Transplant Recipients

    T. Borges,1 J. Azzi,1 S. Tullius,1 A. Chandraker,1 B. Pomahac,2 N. Najafian,1 L. Riella.1

    1Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston; 2Plastic Surgery, Boston.

    Background: Despite the skin being considered the most immunogenic of all human tissues, full facial transplantation (FFT) has become a life transforming procedure with encouraging…
  • 2015 American Transplant Congress

    Does the C1q Assay Predict the Result of Lymphocyte Flow Cross-Match (FCxM) in Potential Renal Transplant Recipients With HLA-DSA and AHG-CDC CxM negative?

    J. Arreola-Guerra, A. de Santiago, A. Arvizu, N. Gonzalez-Tableros, M. Lopez, M. Vilatoba, L. Morales-Buenrostro, J. Alberu, N. Castelan.

    1Transplantation, 1aNephrology-Mineral Metabolism, Inst Nal de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico.

    Background. The presence of pre-transplant HLA donor specific antibodies (DSA) is a recognized risk factor for acute rejection. However, due to the test's (LUMINEX) high…
  • 2015 American Transplant Congress

    Characterization of a Nude Mouse Model of Allosensitization Conditioned by Adoptive Transfer of Follicular T Helper Cells

    I. Kim, N.-N. Chai, S. Jordan, A. Klein, G. Wu.

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.

    Background Follicular T helper (Tfh) cells play a critical role in follicular B cell activation and maturation during antibody responses to allograft. Here we report…
  • 2015 American Transplant Congress

    Marked Suppression of Posttransplant Alloantibody Production and Primed B cell Function In Vivo by mTOR Inhibition Compared to Calcineurin Inhibition

    C. Wright, J. Zimmerer, T. Pham, G. Bumgardner.

    Department of Surgery, CTC, The Ohio State University, Columbus, OH.

    mTOR inhibitors [mTORi; Rapamycin, (Rapa)] and calcineurin inhibitors [CNi; Tacrolimus (Tac)] are immunosuppressives commonly used to suppress rejection of transplants. Despite widespread use following transplantation…
  • 2015 American Transplant Congress

    Combination of Non-HLA and HLA-DSA Antibodies Identifies Liver Transplants Recipients With Highest Risk for Fibrosis Progression and Mortality

    J. O'Leary,1 J. Cai,2 H. Heidecke,3 L. Jennings,1 A. Philippe,4 V. Harbour,1 R. Catar,4 P. Terasaki,2 G. Klintmalm,1 D. Dragun.4

    1Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX; 2Terasaki Foundation Laboratory, Los Angeles, CA; 3Celltrend, Berlin, Germany; 4Nephrology & Intensive Care Medicine, Charite Berlin, Berlin, Germany.

    Recent data has shown an increased risk of fibrosis progression in HCV viremic liver transplant (LT) recipients with HLA DSA in serum. However, the role…
  • 2015 American Transplant Congress

    Preformed Anti-HLA DP Donor Specific Antibodies Are Clinically Significant in Renal Transplantation

    V. Dibbur, M. Willicombe, P. Brookes, R. Sergeant, A. Wardle, D. Taube.

    Renal and Transplant Medicine, Imperial Healthcare NHS Trust, London, United Kingdom.

    Background: Whilst preformed [PF] anti-HLA A, B, DR and DQ donor specific antibodies [DSAbs] are associated with poorer allograft outcomes secondary to antibody mediated injury,…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences